|
ACRV Acrivon Therapeutics Inc 1781174 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-17,964,000.00 |
| Balance Sheet |
|
Current Assets
|
$91,493,000.00 |
|
Assets
|
$99,092,000.00 |
|
Current Liabilities
|
$11,447,000.00 |
|
Liabilities
|
$12,427,000.00 |
|
Equity
|
$86,665,000.00 |
|
Shares Out
|
42847215.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-35,400,000.00 |
|
Investing Cash Flow
|
$28,074,000.00 |
| Market Analysis |
Market Cap
|
$94,263,873.00 |
|
Price
|
$2.20 |
|
BVPS
|
2.02 |
|
PB
|
1.09 |
|
EPS
|
-0.43 |
|
FCF
|
$-35,501,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:53 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:43 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ACRV documents filed with the SEC.
ACRV Filings
Clear
